April 13, 2016

Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.

April 13, 2016

The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.

April 13, 2016
CRN has formed a working group to resolve the specifics of the product registry, which is anticipated will contain multiple tiers of product information.
April 13, 2016

In February, CEO Update named National Association of Chain Drug Stores president and CEO Steve Anderson Trade Association CEO of the Year. DSN looks at some of the more important work accomplished by NACDS under Anderson’s leadership.

April 13, 2016

In the last two years, the FDA has broken its record for the approval of orphan drugs to treat diseases that affect 200,000 or fewer people.

April 13, 2016

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.

April 7, 2016

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

April 6, 2016

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

April 5, 2016

FDA warning letters barring the sale of products containing methylsynephrine  were welcomed by the Council for Responsible Nutrition, which represents dietary supplmement manufacturers and suppliers. 

April 3, 2016

According to the 2015 National Institute on Drug Abuse’s annual Monitoring the Future survey, one in 30 teens abuses OTC cough medicine containing DXM to get high.

March 31, 2016

The complaint alleges that Endo paid Impax Laboratories and Watson Laboratories, which were the first companies to file for FDA approval for generics of Endo’s Opana ER and Lidoderm, to delay their generic product launches. 

March 28, 2016

Last month, the CDC reported preliminary overall influenza vaccine effectiveness of 59% this season. 

March 28, 2016

The fifth edition of this special Rx-Impact report — inserted in headquarter copies of this issue of DSN and delivered to all current members of the U.S. House of Representatives and Senate — is meant to help educate lawmakers on the important role community pharmacy plays as the face of health care in neighborhoods all across America, helping to lower the cost of health care, improving patient access, advancing the quality of care and ultimately delivering better outcomes.

March 25, 2016

More than 1.8 million smokers attempted to quit smoking because of the nine-week-long 2014 Tips From Former Smokers ( Tips ) campaign.

March 24, 2016

Leading up to the budget, CPhA highlighted three priority areas in its pre-budget brief to the Standing Committee on Finance, as well as in its testimony before the Committee.

March 22, 2016

U.S. Reps. Gus Bilirakis, R-Fla., and Kurt Schrader, D-Ore., this week introduced a piece of legislation that is seeking to speed up generic drug approval and creating incentives for competition. 

March 22, 2016

The Food and Drug Administration on Monday finalized the creation of the first-ever Patient Engagement Advisory Committee, the Weinberg Group reported. "The committee has been established in order to provide the FDA commissioner with advice regarding complex issues related to medical devices; specifically regarding the regulation of devices and their use by patients," the report noted. "This was done as part of the agency's 'patient-centric' approach, under which FDA is attempting to ensure the needs and experiences of patients are taken into account during the review of medical devices." (The Weinberg Group)

March 18, 2016

The U.S. House of Representatives passed its largely similar version of the bill (H.R. 471) in April 2015.

March 17, 2016

On the first day of the 2016 NACDS RxIMPACT Day, the National Association of Chain Drug Stores recognized executives from Supervalu, Kinney Drugs and Rite Aid and a student from Presbyterian College School of Pharmacy for their advocacy efforts.

March 17, 2016

The first 30-second ad — called “Effective” — debuted today during the launch of NACDS RxIMPACT Day on Capitol Hill, when nearly 400 pharmacy advocates will meet with 90% of the U.S. Congress to discuss key patient care issues.

March 16, 2016

One-third of the CHPA board of directors is elected annually. Manufacturer members are elected for three-year terms, and associate members are elected for two-year terms. 

March 15, 2016

Like a powerful tide that gradually eats away at the foundations of a once-impregnable sea wall, the booming market for generic drugs advances and recedes with the rise and fall in the number of branded drug patent expirations each year. Download the full Generic Drug Report 2016 to read more.

March 14, 2016

Increasingly, states are looking to address the prescription painkiller problem with as many as 375 proposals coursing through state legislatures that would regulated pain clinics and prescribing painkillers, The New York Times reported Friday. "The states are going to lead on this one because Big Pharma has too much power," Vermont Gov. Peter Shumlin, Democrat, told The New York Times. The New York Times added: "The pace of [legislative] activity in states has grown so intense that experts are having difficulty keeping track." (The New York Times)

March 9, 2016

A judge in August declared that the FDA would limit the company’s first amendment rights if it prevented Amarin from sharing with physicians truthful data that supports a use the FDA hasn’t approved.